Skip to main content

What the FDA labels say about taking them together

Letermovir and pantoprazole

Letermovir's FDA label of January 14, 2026 names pantoprazole in its drug interactions section; the pantoprazole labels PlainMeds reads (4) do not name letermovir. The letermovir label: “Clinical monitoring and dose adjustment may be needed.”

Check it at the source: the letermovir FDA label on DailyMed (effective January 14, 2026, Merck Sharp & Dohme LLC); the pantoprazole FDA label on DailyMed (effective May 18, 2026, Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.).

What does the letermovir label say about pantoprazole?

Letermovir label, drug interactions

Concomitant Drug Class and/or Clearance Pathway/Drug Name: pantoprazole; Effect on Concentration ↓ =decrease, ↑ =increase: ↓ pantoprazole; Clinical Comments: Clinical monitoring and dose adjustment may be needed.

Source: FDA drug label (PREVYMIS), Merck Sharp & Dohme LLC, effective January 14, 2026 (SPL set 1b49df80-be4f-47e0-a0b7-123f3e69395b), via openFDA; the full label on DailyMed

What does the pantoprazole label say about letermovir?

Pantoprazole's label (effective May 18, 2026) and its 3 other brand-application labels do not name letermovir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Protonix Delayed-Release), Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., effective May 18, 2026 (SPL set 08098cb2-c048-4640-f387-6beec4a38936), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Letermovir generic labelers
66Pantoprazole generic labelers
LetermovirPantoprazole
Labeled forn/aAcid reflux and ulcers
Boxed warningNoNo
Pharmacy cost (NADAC)n/a$0.0358 per tablet 40 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?